Arbutus Biopharma (ABUS) Earnings Date, Estimates & Call Transcripts → Look what happened to Netflix during these “Hotspot Dates” (From The TradingPub) (Ad) Free ABUS Stock Alerts $3.35 +0.06 (+1.82%) (As of 05/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 2) -$0.10 Consensus EPS (May. 2) -$0.10 Get Arbutus Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for ABUS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueABUS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABUS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. Arbutus Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.17)($0.17)($0.17)Q2 20241($0.17)($0.17)($0.17)Q3 20241($0.18)($0.18)($0.18)Q4 20241($0.18)($0.18)($0.18)FY 20244($0.70)($0.70)($0.70)ABUS Earnings Date and InformationArbutus Biopharma last issued its earnings results on May 2nd, 2024. The biopharmaceutical company reported ($0.10) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.10). The firm had revenue of $1.53 million for the quarter, compared to analysts' expectations of $2.16 million. Arbutus Biopharma has generated ($0.44) earnings per share over the last year (($0.44) diluted earnings per share). Earnings for Arbutus Biopharma are expected to decrease in the coming year, from ($0.39) to ($0.41) per share. Arbutus Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Arbutus Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/2/2024Q1 2024($0.10)($0.10)-($0.10)$2.16 million$1.53 million2/29/2024Q4 2023($0.12)($0.12)-($0.12)$4.74 million$2.15 million 11/7/2023Q3 2023($0.12)($0.12)-($0.12)$3.78 million$4.66 million8/3/2023Q2 2023($0.12)($0.10)+$0.02($0.10)$5.02 million$4.65 million5/4/2023Q1 2023($0.14)($0.10)+$0.04($0.10)$4.52 million$6.69 million3/2/2023Q4 2022($0.14)($0.14)-($0.14)$6.31 million$6.25 million Get the Latest News and Ratings for ABUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/9/2022Q3 2022($0.12)($0.12)-($0.12)$11.12 million$5.95 million8/4/2022Q2 2022($0.13)($0.10)+$0.03($0.10)$5.37 million$14.24 million 5/5/2022Q1 2022($0.13)($0.11)+$0.02($0.11)$5.77 million$12.58 million 3/3/2022Q4 2021($0.16)($0.15)+$0.01($0.15)$3.39 million$3.21 million 11/4/2021Q3 2021($0.24)($0.24)-($0.24)$2.36 million$3.34 million 8/4/2021Q2 2021($0.21)($0.23)($0.02)($0.23)$2.07 million$2.33 million 5/4/2021Q1 2021($0.23)($0.21)+$0.02($0.21)$3.87 million$2.11 million 3/3/2021Q4 2020($0.22)($0.23)($0.01)($0.23)$2.12 million$2.39 million 11/10/2020Q3 2020($0.22)($0.27)($0.05)($0.27)$1.81 million$1.52 million 8/7/2020Q2 2020($0.24)($0.25)($0.01)($0.25)$1.85 million$1.51 million 5/11/2020Q1 2020($0.31)($0.25)+$0.06($0.25)$1.81 million$1.49 million 3/5/2020Q4 2019($0.37)($0.36)+$0.01($0.26)$1.46 million$1.61 million11/6/2019Q3 2019($0.11)($0.33)($0.22)$0.84$9.85 million$3.10 million 8/5/2019Q2($0.35)($0.46)($0.11)($0.46)$0.88 million$0.70 million Arbutus Biopharma Earnings - Frequently Asked Questions When is Arbutus Biopharma's earnings date? Arbutus Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on ABUS's earnings history. Did Arbutus Biopharma beat their earnings estimates last quarter? In the previous quarter, Arbutus Biopharma (NASDAQ:ABUS) reported ($0.10) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.10). Learn more on analysts' earnings estimate vs. ABUS's actual earnings. How much revenue does Arbutus Biopharma generate each year? Arbutus Biopharma (NASDAQ:ABUS) has a recorded annual revenue of $18.14 million. How much profit does Arbutus Biopharma generate each year? Arbutus Biopharma (NASDAQ:ABUS) has a recorded net income of -$72.85 million. ABUS has generated -$0.44 earnings per share over the last four quarters. What is Arbutus Biopharma's EPS forecast for next year? Arbutus Biopharma's earnings are expected to decrease from ($0.39) per share to ($0.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies: PHAR Earnings Results ORIC Earnings Results SVRA Earnings Results PHAT Earnings Results HROW Earnings Results ZYME Earnings Results CDMO Earnings Results CALT Earnings Results MLYS Earnings Results AVTE Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: TD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's Earnings This page (NASDAQ:ABUS) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWall Street Legend Warns: "A Strange Day Is Coming to America"Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arbutus Biopharma Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
